Trial Details
Not recruitingBasic Information
| Clinical ID | c3345 |
|---|---|
| Identifier | NCT00475410 |
| Trial Title | A Phase III Multicenter, Single Blind, Randomized, Comparative and add-on Clinical Trial, in Three Parallel Groups, to Evaluate Efficacy and Safety of a New Therapy With Adipose-derived Autologous Stem Cells for the Treatment of Complex Perianal Fistulas in Patients Without Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Anal Fistula |
| Interventions | Drug: ASCs (Cx401, company code);Drug: Fibrin adhesive |
Participant Information
| Sponsor | Tigenix S.A.U. |
|---|---|
| City | - |
| Country/Region | Germany;Spain;United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |